Poultry vaccines are an important component of poultry disease prevention and control. A vaccine helps to avoid a particular disease by boosting the bird’s immune system to produce antibodies which will fight the invading causal organisms. Handling and administration procedures influence the potency of many vaccines and consequently the level of immunity the bird develops. Most of the poultry killed vaccines are developed against viral diseases. A poultry vaccination program depends on several factors such as type of production, level of biosecurity, local pattern of disease, status of maternal immunity, availability of vaccines, and costs and potential losses. Vaccines are administered through different routes such as in vivo, intramuscular, subcutaneous, ocular, oral, and nasal. Vaccines can be applied to five different areas of the egg such as the air cell, allantoic sac, amniotic fluid, body of embryo, and yolk sac. Hygiene management, including reduced air circulation, well maintained air filters, adjustment to weather conditions, and well maintained hatchery insulation, is important for in vivo vaccination.
Factors such as government initiatives, rapid growth of poultry population, and increasing incidence of zoonotic diseases, technological advancement, and growing demand for poultry derived food products and poultry vaccination are the key accelerating factors for the growth of the global poultry vaccines market. According to Merial Health, by 2020, chicken is projected to overtake pork as the global animal protein of choice, and the poultry industry is likely to play an even more crucial role in ensuring food for the future global populations. In addition, new vaccine innovation, vaccination programs by leading players, and animal health care expenditure are factors fueling the growth of the global poultry vaccines market. However, rising maintenance cost for the storage of vaccine and increasing adoption of vegetarian food may negatively affect the market growth.
The global poultry vaccines market has been segmented based on product type, dosage form, application, end-user, and region. In terms of product type, the market is classified into modified or attenuated (live), inactivated (killed), and recombinants. In terms of dosage form, the market is segmented into liquid vaccine, freeze dried vaccine, and duct (dry form). In terms of application, the global market for poultry vaccines is classified into Newcastle disease, Marek’s disease, infectious bronchitis, infectious bursal disease, and others. In terms of end-user, the market is segmented into veterinary hospitals, poultry vaccination centers, and poultry firms.
Geographically, the global poultry vaccines market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the global poultry vaccines market due to factors such as technological advancement, increasing poultry inventories, growing demand for poultry derived products, and increasing investment in animal health. According to the National Chicken Council, the per capita consumption of poultry was 107.6 pounds in 2016 and is expected to reach 109.5 pounds in 2018. Europe is the second largest market for poultry vaccines globally. Asia Pacific is expected to expand at a high growth rate due to increasing poultry production, government vaccination program, and rising veterinary health care expenditure. These factors are projected to drive the Asia Pacific market in the near future. According to ETRetail.com, India is currently the second fastest growing market for processed meat and poultry globally, accounting for 24% of processed meat, poultry, and fish product innovations. Indonesia stands first in this category followed by Vietnam, China, and Brazil.
Major players operating in this market include Ceva Animal Health LLC, Zoetis Inc., Eli Lilly and Company, Indovax Private Limited, Hester Biosciences Limited, S.C ROMVAC COMPANY S.A., Boehringer Ingelheim Vetmedica, Inc., and Intervet India Pvt. Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.